An Intranasal Vaccine Based on Outer Membrane Vesicles Against SARS-CoV-2.

Thapa, Himadri B; Müller, Anna M; Camilli, Andrew; Schild, Stefan

Thapa, Himadri B; Müller, Anna M; Camilli, Andrew; Schild, Stefan.

Afiliação

Thapa HB; Institute of Molecular Biosciences, University of Graz, Graz, Austria.
Müller AM; Institute of Molecular Biosciences, University of Graz, Graz, Austria.
Camilli A; Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA, United States.
Schild S; Institute of Molecular Biosciences, University of Graz, Graz, Austria.

Front Microbiol ; 12: 752739, 2021.

Article em En | MEDLINE | ID: mdl-34803974

Palavras-chave

RBD; SARS-CoV-2; Spike protein; Vibrio cholerae; enterotoxigenic Escherichia coli; outer member vesicles (OMV); outer membrane vesicles

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Idioma: En Revista: Front Microbiol Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google